Real world Clinical Outcomes with Novel Modulator Therapy Combinations in People with CF (RECOVER).

This study will examine the impact of TCM on various aspects of the lives and health of adults with cystic fibrosis. (Triple combination CFTR modulator therapy (TCM).

Key Eligibility Criteria

Cystic Fibrosis, Age 18+

Therapeutic Area

Cystic Fibrosis

Type of Study

Observational Study

Study Status

Not-Recruiting

Sponsor

RCSI

Principal Investigator

Prof Edward McKone

Contact

Brenda.grogan@ucd.ie